📊 BUDZ Key Takeaways
Is Weed, Inc.. (BUDZ) a Good Investment?
WEED, INC. exhibits severe financial distress with zero revenue, negative stockholders equity of -$447.9K, and deteriorating cash burn of -$70.5K in operating cash flow. The company is technically insolvent with liabilities exceeding assets by $447.9K, leaving no margin for error and indicating critical viability concerns.
The fundamentals are extremely weak: the company reported zero revenue, ongoing operating losses, negative operating and free cash flow, and a deeply stressed balance sheet. Negative equity, minimal cash, and a current ratio of 0.02x indicate severe financial fragility, while the absence of revenue suggests there is no evidence of sustainable operating traction.
Why Buy Weed, Inc.. Stock? BUDZ Key Strengths
- Minimal capital expenditure requirements suggests asset-light business model
- Some insider activity indicates management awareness and potential engagement
- Classification in research services sector allows for potential pivot or licensing opportunities
- Reported net loss is relatively small versus operating loss, which may reflect limited non-operating burden in the latest period
- No capital expenditure requirements in the latest period may reduce near-term cash demands
- Asset base is still positive, providing at least some residual operating foundation
BUDZ Stock Risks: Weed, Inc.. Investment Risks
- Zero revenue generation with no clear path to commercialization
- Negative stockholders equity represents technical insolvency and existential solvency risk
- Severe liquidity crisis with current ratio of 0.02x and only $5.3K cash against $996.8K liabilities
- Ongoing negative cash burn of -$70.5K with minimal liquidity runway of less than 1 month
- Operating losses of -$528.8K indicate non-viable core business operations
- Zero revenue indicates no demonstrated business scale or earnings power
- Negative stockholders equity and total liabilities exceeding assets signal balance-sheet distress
- Very low cash balance and negative operating cash flow raise substantial liquidity and going-concern risk
Key Metrics to Watch
- Revenue generation and path to positive cash flow
- Stockholders equity trajectory and recapitalization efforts
- Cash burn rate and remaining liquidity runway
- Debt restructuring or capital raise announcements
- Revenue generation and consistency of any top-line growth
- Cash balance, operating cash burn, and improvement in working capital / current ratio
Weed, Inc.. (BUDZ) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BUDZ Profit Margin, ROE & Profitability Analysis
BUDZ vs Healthcare Sector: How Weed, Inc.. Compares
How Weed, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Weed, Inc.. Stock Overvalued? BUDZ Valuation Analysis 2026
Based on fundamental analysis, Weed, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Weed, Inc.. Balance Sheet: BUDZ Debt, Cash & Liquidity
BUDZ Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Weed, Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.00 indicates the company is currently unprofitable.
BUDZ Revenue Growth, EPS Growth & YoY Performance
BUDZ Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | N/A | -$95.9K | $0.00 |
| Q1 2025 | N/A | -$95.9K | $0.00 |
| Q3 2024 | N/A | -$95.9K | N/A |
| Q2 2024 | N/A | -$111.0K | N/A |
| Q1 2024 | N/A | -$31.6K | N/A |
| Q3 2021 | N/A | -$173.3K | N/A |
| Q1 2021 | N/A | -$971.7K | N/A |
| Q3 2020 | N/A | -$176.6K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Weed, Inc.. Dividends, Buybacks & Capital Allocation
BUDZ SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Weed, Inc.. (CIK: 0001393772)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BUDZ
What is the AI rating for BUDZ?
Weed, Inc.. (BUDZ) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 94% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BUDZ's key strengths?
Claude: Minimal capital expenditure requirements suggests asset-light business model. Some insider activity indicates management awareness and potential engagement. ChatGPT: Reported net loss is relatively small versus operating loss, which may reflect limited non-operating burden in the latest period. No capital expenditure requirements in the latest period may reduce near-term cash demands.
What are the risks of investing in BUDZ?
Claude: Zero revenue generation with no clear path to commercialization. Negative stockholders equity represents technical insolvency and existential solvency risk. ChatGPT: Zero revenue indicates no demonstrated business scale or earnings power. Negative stockholders equity and total liabilities exceeding assets signal balance-sheet distress.
What is BUDZ's revenue and growth?
Weed, Inc.. reported revenue of $0.0.
Does BUDZ pay dividends?
Weed, Inc.. does not currently pay dividends.
Where can I find BUDZ SEC filings?
Official SEC filings for Weed, Inc.. (CIK: 0001393772) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BUDZ's EPS?
Weed, Inc.. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BUDZ a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Weed, Inc.. has a STRONG SELL rating with 94% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BUDZ stock overvalued or undervalued?
Valuation metrics for BUDZ: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy BUDZ stock in 2026?
Our dual AI analysis gives Weed, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BUDZ's free cash flow?
Weed, Inc..'s operating cash flow is $-70.5K, with capital expenditures of $0.0.
How does BUDZ compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.02 (avg: 2).